Finally, investigators studying conversion of pre-leukemic acute myeloid leukemia (AML) cells with TET2 mutations to full-blown AML have identified a significant role of Ref-1/APE1 in this process. The gene discussed is APEX1; the disease is acute myeloid leukemia.